# Bob T. Li

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/bob-t-li/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,778 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 60 |
| i10-index | 159 |
| Last Known Institution | Memorial Sloan Kettering Cancer Center |
| OpenAlex ID | https://openalex.org/A5042115782 |
| ORCID iD | https://orcid.org/0000-0001-6661-8733 |
| Works | 606 |

## Researcher papers

- [Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation](https://scholariq.org/papers/sotorasib-for-lung-cancers-with-i-kras-i-p-g12c-mutation/)
- [KRAS <sup>G12C</sup> Inhibition with Sotorasib in Advanced Solid Tumors](https://scholariq.org/papers/kras-sup-g12c-sup-inhibition-with-sotorasib-in-advanced-solid-tumors/)
- [The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers](https://scholariq.org/papers/the-genomic-landscape-of-endocrine-resistant-advanced-breast-cancers/)
- [Trastuzumab Deruxtecan in <i>HER2</i> -Mutant Non–Small-Cell Lung Cancer](https://scholariq.org/papers/trastuzumab-deruxtecan-in-i-her2-i-mutant-non-small-cell-lung-cancer/)
- [High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants](https://scholariq.org/papers/high-intensity-sequencing-reveals-the-sources-of-plasma-circulating-cell-free/)
- [Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies](https://scholariq.org/papers/prospective-comprehensive-molecular-characterization-of-lung-adenocarcinomas-for/)
- [HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung Cancers](https://scholariq.org/papers/her2-mediated-internalization-of-cytotoxic-agents-in-i-erbb2-i-amplified-or/)
- [Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer](https://scholariq.org/papers/overall-survival-with-circulating-tumor-dna-guided-therapy-in-advanced-non-small/)
- [Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer](https://scholariq.org/papers/clinical-utility-of-prospective-molecular-characterization-in-advanced/)
- [Automated real-world data integration improves cancer outcome prediction](https://scholariq.org/papers/automated-real-world-data-integration-improves-cancer-outcome-prediction/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Researcher university

- [Memorial Sloan Kettering Cancer Center](https://scholariq.org/institutions/memorial-sloan-kettering-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.